Literature DB >> 18227713

The burden of varicella complications before the introduction of routine varicella vaccination in Germany.

Johannes G Liese1, Veit Grote, Eva Rosenfeld, Richela Fischer, Bernd H Belohradsky, Rüdiger v Kries.   

Abstract

BACKGROUND: The true burden of varicella complications in Germany is not known. We investigated the incidence and pattern of varicella complications in children and adolescents using 3 independent surveillance sources.
METHODS: Prospective nationwide surveillance in all pediatric hospitals through the German Pediatric Surveillance Unit [Erhebungseinheit für Seltene Pädiatrische Erkrankungen in Deutschland (ESPED)] was used to ascertain hospitalized varicella cases in children <or=16 years of age between January 2003 and December 2004. In the federal state, North-Rhine Westphalia (NRW), a practice sentinel network [European Diabetes Study Group (EURODIAB)] and pediatric hospital based International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) surveillance were additionally used to refine incidence estimates via capture-recapture methodology.
RESULTS: A total of 918 hospitalized varicella patients (male-to-female: 55%/45%) with a median age of 3.3 years (interquartile range, 1.4-5.2) and a median hospital stay of 5 days (interquartile range, 3-8) were reported. Varicella associated complications occurred in 80% of the hospitalizations, most frequently being neurologic (25.4%), skin infectious (23.2%), and gastrointestinal tract complications (15.0%). Most hospitalizations (77%) occurred in previously healthy children. A predisposing condition existed in 207 children (23%): immunosuppression 7%, atopic dermatitis 7%, and other underlying chronic conditions 9%. Severity of varicella complications was related to increasing age and immunosuppression. Permanent or possible sequelae were reported in 15 (1.7%) and 78 (8.7%) of all children, respectively; 10 children died. Capture-recapture analyses yielded an incidence of 14.1 (95% confidence interval, 9.7-18.6) varicella hospitalizations/100,000 children, corresponding to 1996 (95% confidence interval, 1363-2629) varicella-related hospitalizations per year in Germany.
CONCLUSIONS: These data show that the severity of varicella complications in healthy children has been previously underestimated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227713     DOI: 10.1097/INF.0b013e3181586665

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  39 in total

1.  Fifteen years of routine childhood varicella vaccination in the United States-strong decrease in the burden of varicella disease and no negative effects on the population level thus far.

Authors:  Andrea Streng; Johannes G Liese
Journal:  Transl Pediatr       Date:  2014-10

Review 2.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

3.  Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany.

Authors:  Anette Siedler; Marleen Dettmann
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Toxin profiling of Staphylococcus aureus strains involved in varicella superinfection.

Authors:  Olivia Raulin; Géraldine Durand; Yves Gillet; Michèle Bes; Gerard Lina; François Vandenesch; Daniel Floret; Jerome Etienne; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2010-03-19       Impact factor: 5.948

5.  The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study).

Authors:  Ener Cagri Dinleyici; Zafer Kurugol; Ozden Turel; Nevin Hatipoglu; Ilker Devrim; Hasan Agin; Ilker Gunay; Olcay Yasa; Muferet Erguven; Nuri Bayram; Ali Kizildemir; Emre Alhan; Emine Kocabas; Hasan Tezer; H Hakan Aykan; Nazan Dalgic; Betul Kilic; Gulnar Sensoy; Nursen Belet; Nihan Uygur Kulcu; Aysu Say; Mehmet Ali Tas; Ergin Ciftci; Erdal Ince; Halil Ozdemir; Melike Emiroglu; Dursun Odabas; Zeynel Abidin Yargic; Cagatay Nuhoglu; Kursat Bora Carman; Solmaz Celebi; Mustafa Hacimustafaoglu; Murat Elevli; Zahide Ekici; Umit Celik; Meda Kondolot; Mustafa Ozturk; Anil Tapisiz; Metehan Ozen; Harun Tepeli; Aslinur Parlakay; Ates Kara; Ayper Somer; Bahar Caliskan; Sevtap Velipasalioglu; Selim Oncel; Emin Sami Arisoy; Ekrem Guler; Tahir Dalkiran; Denizmen Aygun; Saadet Akarsu
Journal:  Eur J Pediatr       Date:  2011-12-16       Impact factor: 3.183

6.  Varicella: efficacy of two-dose vaccination in childhood.

Authors:  Peter Wutzler; Markus Knuf; Johannes Liese
Journal:  Dtsch Arztebl Int       Date:  2008-08-15       Impact factor: 5.594

7.  Acceptance of varicella vaccination.

Authors:  Andrea Horváth
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

8.  Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands.

Authors:  Jorien G J Pierik; Pearl D Gumbs; Sander A C Fortanier; Pauline C E Van Steenwijk; Maarten J Postma
Journal:  BMC Infect Dis       Date:  2012-05-10       Impact factor: 3.090

9.  Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011.

Authors:  Andrea Streng; Veit Grote; David Carr; Christine Hagemann; Johannes G Liese
Journal:  BMC Infect Dis       Date:  2013-07-02       Impact factor: 3.090

10.  Seroepidemiology of Varicella Zoster Virus among children, adolescents and medical students in a referral children medical center, Tehran, Iran.

Authors:  B Pourakbari; L Shahbaznezhad; N Parvaneh; S Nikkhah; S Mahmoudi; M Teymuri; Ae Alyari; S Mamishi
Journal:  Iran J Microbiol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.